# Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

> **NCT05586711** · PHASE4 · COMPLETED · sponsor: **Angelica Lindén Hirschberg** · enrollment: 170 (actual)

## Conditions studied

- Vulvovaginal Atrophy
- Genitourinary Syndrome of Menopause

## Interventions

- **DRUG:** vaginal estradiol 10 μg
- **DRUG:** vaginal DHEA 6.5 mg

## Key facts

- **NCT ID:** NCT05586711
- **Lead sponsor:** Angelica Lindén Hirschberg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-18
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586711, "Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05586711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*